Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic
- Description
Data was abstracted from NYU Langone Health electronic health records, the Perlmutter Cancer Center Data Hub, and the NYU Langone Health SARS-CoV-2 Data Mart for all patients treated for breast cancer at Perlmutter Cancer Center either through telemedicine or in-person between February 1, 2020 and May 1, 2020 to determine the incidence of SARS-CoV-2 infection associated with treatment with cytotoxic chemotherapy (CT) or non-cytotoxic therapy (E/H). Hospitalization information was collected from NYU Langone Health Hospitals (i.e., NYU Langone Medical Center, NYU Langone Hospital – Brooklyn, NYU Langone Hospital – Long Island). Additional outcomes of interest were differences in incidence of SARS-CoV-2 infection by specific treatment agent (including no treatment) and the severity of COVID-19 outcomes between treatment groups.
The dataset includes patient demographic information, oncologic treatment history (including active treatment course), SARS-CoV-2 status, and clinical status at the time of last follow-up. Cancer staging data were obtained from the cancer staging field or notes field via natural language processing. Causes of death were determined through physician review of medical records; any patient diagnosed with SARS-CoV-2 who died during the follow up period was considered a death due to SARS-CoV-2 in this study. A total of 3,262 patients were included, of which 641 patients received RT-PCR or serology SARS-COV-2 testing.
- Timeframe
- 2020
- Geographic Coverage
-
New York (State)New York (State) - New York City
Access
- Restrictions
-
Application RequiredAuthor Approval Required
- Instructions
- Please complete the Data Request Form to request access to this dataset through collaboration. The information included in the form will be sent to the Corresponding Author who will evaluate your request for their data. The Corresponding Author may ask you to provide additional information if necessary.